Navigation Links
Interim Clinical Trial Results Confirm Safety of Renadyl™, a Probiotic Dietary Supplement for the Support of Healthy Kidney Function
Date:3/8/2012

ountries' governmental rules and regulatory authorities.

About Uremic Toxin Reduction Technology

Kibow's novel "uremic toxin removal technology" addresses the diffusion of various uremic toxins into the bowel as a consequence of failing kidney function. The Company's patented and proprietary dietary supplements, Renadyl™ (for CKD patients) and Azodyl™ (veterinary formulation) consist of a combination of three specific probiotic microbial strains. The results of a randomized, double-blind, crossover, pilot scale clinical trial completed in 2010 provided encouraging preliminary evidence that the Company's technology could be effective when the formulation is taken together with the standard therapy according to individual patient conditions.

Forward-looking statements

This press release contains forward-looking statements that reflect management's current views of future events, including the status of development of the dietary supplement formulation, Renadyl™, for kidney health in the USA and the possibility of its approval as a drug in some other countries according to respective governmental authorities. Kibow is not a pharmaceutical company. Kibow products are not drugs and may not be considered as a treatment or a therapy. The dietary supplement formulation of Renadyl™ will not cure, prevent or mitigate any disease. Actual results may differ significantly from the above forward-looking statements due to a number of factors including but not limited to the possibility that Renadyl™ may not prove to be safe or show evidence of clinical activity in the current limited human trials or that data from patients enrolled in the study may not be useful or conclusive or sufficient to guide future development of Renadyl™. Other factors that could cause or contribute to differences in actual results include, but are not limited to, whether or not the Company or any of its collaborators will be able to de
'/>"/>

SOURCE Kibow Biotech, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Chromos obtains interim order in connection with arrangement, announces annual and special meeting of shareholders and confirms mailing of information circular
2. BioMS Medical announces positive interim analysis on phase III trial of dirucotide (MBP8298) for multiple sclerosis
3. Fufeng Announces 2008 Interim Results With Strong Sign of Recovery
4. LPBP Inc. - Re-filing certification of interim filings
5. Bavarian Nordic A/S - Interim Report for the Period 1 January to 30 June 2008
6. Arpida Reports Interim Results for Six Months to 30 June 2008
7. Exiqon A/S: Interim Report for the Period 1 January - 30 June 2008 (Unaudited)
8. Nile Therapeutics Announces Positive Interim Data from Phase 2a Study of CD-NP in Patients with Heart Failure
9. Misonix Announces Interim Distribution Agreement for Italy
10. Oncolytics Biotech Inc. Investigators Present Interim U.S. REOLYSIN(R) Phase II Sarcoma Trial Data
11. Interim Analysis of Data from e-HEALING Registry of OrbusNeichs Genous(TM) Bio-engineered R stent(TM) to be Presented at AHA Scientific Sessions 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... 31, 2014 “Rapid technological advances ... the U.S., increasing unemployment, depressing American consumer spending ... is a Catch 22—we need automated manufacturing if ... fewer jobs,” says economist and corporate relocation expert ... Top 10 Pro-Business States for 2014, co-published with ...
(Date:7/31/2014)... Sales Horizons, a leader in sales training, today ... – Mastering the Complex Sale – to ... proven sales training programs used by thousands of salespeople ... sales training course is available to every salesperson as ... customers, like technical support, engineers, clinical support, and IT ...
(Date:7/30/2014)... 30, 2014 A study presented at ... and efficacy of CSL Behring,s C1 Inhibitor (C1-INH) ... in highly sensitized patients. C1-INH is a human ... system. The study shows that post-transplant ... the levels of complement components 3 and 4, ...
(Date:7/30/2014)... (PRWEB) July 30, 2014 Sales Horizons, ... launch of blended sales training programs for companies engaged ... training programs used by thousands of salespeople over 25 ... sales training program can be customized to address the ... The blended sales training program consists of ...
Breaking Biology Technology:ITRA Global Affiliate’s Pollina Corporate Top 10 Pro-Business States Minimize the Impact of Automation on Middle Class and Unemployment 2ITRA Global Affiliate’s Pollina Corporate Top 10 Pro-Business States Minimize the Impact of Automation on Middle Class and Unemployment 3ITRA Global Affiliate’s Pollina Corporate Top 10 Pro-Business States Minimize the Impact of Automation on Middle Class and Unemployment 4Sales Horizons Offers Mastering the Complex Sale - a Comprehensive, Online Sales Skills Training Course 2Sales Horizons Offers Mastering the Complex Sale - a Comprehensive, Online Sales Skills Training Course 3Study Suggests C1-INH May Aid in Prevention of Antibody-Mediated Rejection Following Kidney Transplant 2Study Suggests C1-INH May Aid in Prevention of Antibody-Mediated Rejection Following Kidney Transplant 3Sales Horizons Launches New Blended Sales Training Programs to Companies Engaged in Complex B2B Sales 2Sales Horizons Launches New Blended Sales Training Programs to Companies Engaged in Complex B2B Sales 3
... Technology (TU/e) have for the first time made ... formation. They used the world,s most advanced electron ... that are at the heart of the process. ... and shell formation. For industrial applications, they promise ...
... WYE ) announced today that it will present ... Conference on Tuesday, March 17, 2009 at 9:30 a.m. ... Dolsten, M.D., Ph.D., President, Wyeth Research and Senior Vice ... at www.wyeth.com and available for replay following ...
... Collaboration in Biomarker Research, Leading to Faster Medical SolutionsWALTHAM, ... global open innovation marketplace, and FasterCures ... announced that two InnoCentive Solvers have been awarded $5,000 ... FasterCures posted to InnoCentive,s online network in ...
Cached Biology Technology:First high-resolution images of bone, tooth and shell formation 2Wyeth to Present at the SG Cowen & Co. 29th Annual Healthcare Conference 2FasterCures Rewards Two InnoCentive Solvers for Innovative Ideas to Accelerate Medical Research 2FasterCures Rewards Two InnoCentive Solvers for Innovative Ideas to Accelerate Medical Research 3FasterCures Rewards Two InnoCentive Solvers for Innovative Ideas to Accelerate Medical Research 4FasterCures Rewards Two InnoCentive Solvers for Innovative Ideas to Accelerate Medical Research 5
(Date:7/30/2014)... two points is a straight line, and now Harvard ... familiar axiom to heart. , Though competition among ... each racing for the chance to fertilize the egg, ... groups that allow them to take a straighter path ... by Heidi Fisher, a post-doctoral student working in the ...
(Date:7/30/2014)... Antonio Life Sciences Institute (SALSI), a joint venture between ... The University of Texas Health Science Center at San ... Pilot Program. The winners, Emily Boice from UTSA and ... $25,000 for their project titled, "Novel engineered ferritins for ... , Boice and Huang,s research is focused on finding ...
(Date:7/30/2014)... of $1 million from the Cornelia Cogswell Rossi Foundation ... Center. , The newly established Connie Cogswell ... develop a greater breadth and depth of knowledge of ... pace of research to improve human health. , The ... the Laboratory and its external partners, supporting research to ...
Breaking Biology News(10 mins):When cooperation counts 2When cooperation counts 3Rossi Foundation pledges $1M for JAX neurobehavioral research center 2
... , Billfish and tuna, important commercial and recreational fish ... of shrinking habitat, according to a new study published ... of Miami Rosenstiel School of Marine and Atmospheric Science. ... as a hypoxic zone, in the Atlantic Ocean is ...
... Seven projects responding to the nation,s Grand Challenges ... by Deirdre Meldrum, dean of the Ira A. Fulton ... announced Grand Challenges Research Seed Funding grants of approximately ... will lead research to answer the call of the ...
... at the University of Minnesota have discovered how HIV ... called APOBEC3F. The results suggest that a simple chemical ... agent and that shielding of a common feature shared ... This discovery highlights the potential for a novel approach ...
Cached Biology News:Growing hypoxic zones reduce habitat for billfish and tuna 2Grants fund projects that will tackle 'Grand Challenges' 2Grants fund projects that will tackle 'Grand Challenges' 3Grants fund projects that will tackle 'Grand Challenges' 4Grants fund projects that will tackle 'Grand Challenges' 5University of Minnesota discovery suggests a new way to prevent HIV from infecting human cells 2
Request Info...
... Bean Nuclease catalyzes the degradation of single-stranded ... terminated products. While the nuclease prefers ssDNA ... concentrations the enzyme degrades double-stranded DNA from ... been used for transcript mapping studies (3,4), ...
... fosmid (40kb), and large plasmid insert (10-20kb) ... BAC vector. On command 20-50 fold copy ... DNA purification. Available with blue-white screening (pEZ ... the highest insert stability. Kits include electrocompetent ...
...
Biology Products: